Several reports of patients with BRAF V600K‐mutated MMs also described significant differences in sex, age, primary MM location, the interval from MM first diagnosis to Stage IV disease and the overall survival after the diagnosis of Stage IV disease. The gene discussed is BRAF; the disease is Miyoshi myopathy.